Cogenics, Inc.
Records under this name other than patents Cogenics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,577,754 | Robust Stain Detection and Quantification for Histological Specimens Based on a Physical Model for Stain Absorption Formerly held Term ended Term ended May 29, 2022 · High confidence | Term ended | Term ended May 29, 2022 | High confidence |
| US 6,819,787 | Robust Stain Detection and Quantification for Histological Specimens Based on a Physical Model for Stain Absorption Formerly held Term ended Ended no later than May 29, 2022 · Medium confidence | Term ended | Ended no later than May 29, 2022 | Medium confidence |
| US 6,586,183 | Association of &bgr;2-adrenergic receptor haplotypes with drug response Formerly held Term ended Term ended Apr 13, 2020 · From the USPTO record | Term ended | Term ended Apr 13, 2020 | From the USPTO record |
| US 6,581,011 | Online database that includes indices representative of a tissue population Formerly held Term ended Ended no later than Jun 23, 2019 · From the USPTO record | Term ended | Ended no later than Jun 23, 2019 | From the USPTO record |
| US 6,611,833 | Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population Formerly held Term ended Ended no later than Jun 23, 2019 · From the USPTO record | Term ended | Ended no later than Jun 23, 2019 | From the USPTO record |
| US 6,993,170 | Method for Quantitative Analysis of Blood Vessel Structure Formerly held Term ended Term ended Jun 23, 2019 · Medium confidence | Term ended | Term ended Jun 23, 2019 | Medium confidence |
| US 6,479,236 | Genotyping the human UDP-glucuronosyltransferase 1 (UGT1) gene Formerly held Lapsed on the fee record Ended Nov 12, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 12, 2014 | From the USPTO record |
| US 6,929,912 | Methods for Evaluating the Ability to Metabolize Pharmaceuticals Formerly held Lapsed on the fee record Ended Aug 16, 2013 · Medium confidence | Lapsed on the fee record | Ended Aug 16, 2013 | Medium confidence |
| US 7,250,258 | CDK5 Genetic Markers Associated with Galantamine Response Formerly held Lapsed on the fee record Ended Jul 31, 2011 · High confidence | Lapsed on the fee record | Ended Jul 31, 2011 | High confidence |
| US 6,944,767 | Methods and apparatus for ensuring the privacy and security of personal medical information Formerly held Lapsed on the fee record Ended Sep 13, 2009 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2009 | From the USPTO record |